Setting

Global Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Region: Trend Forecast and Growth Opportunity

Published: 30 Jun 2022 | Report Code: 10248542 | Pages: 178

Global nutrigenomics market will reach $2,691.3 million by 2031, growing by 15.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 86 tables and 91 figures, this 178-page report “Global Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Region. Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Products o Probiotics o Prebiotics o Vitamins & Supplements • Testing Services o Nutrigenomics Clinical Testing o Nutrigenomics Research Testing Based on Test Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Next-generation Sequencing • Real-time PCR • DNA Microarray • Sanger Sequencing By Test Sample, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Buccal Swab Sample • Saliva Sample • Blood Sample • Other Samples By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Women’s Health • Metabolic Disorders • Immune Health • Cancer Research • Cardiovascular Diseases • Diabetes • Other Applications By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Nutrition Clinics • Diagnostics Laboratories • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE?Saudi Arabia? South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Offering?Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BASF SE BioGaia Cell Logic Cura Integrative Medicine DNAfit DuPont de Nemours, Inc. Garden of Life, LLC GeneOmbio Genova Diagnostics, Inc. GX Sciences, Inc. Ingredion Incorporated Jarrow Formulas Inc. Koninklijke DSM N.V. MedGenome Metagenics, Inc. Nutrigenomix Inc. Unilever Group XCODE Life Yakult Honsha Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction	9
1.1 Industry Definition and Research Scope	9
1.1.1 Industry Definition	9
1.1.2 Research Scope	10
1.2 Research Methodology	13
1.2.1 Overview of Market Research Methodology	13
1.2.2 Market Assumption	14
1.2.3 Secondary Data	14
1.2.4 Primary Data	14
1.2.5 Data Filtration and Model Design	15
1.2.6 Market Size/Share Estimation	16
1.2.7 Research Limitations	17
1.3 Executive Summary	18
2 Market Overview and Dynamics	21
2.1 Market Size and Forecast	21
2.1.1 Impact of COVID-19 on World Economy	22
2.1.2 Impact of COVID-19 on the Market	26
2.2 Major Growth Drivers	28
2.3 Market Restraints and Challenges	36
2.4 Emerging Opportunities and Market Trends	39
2.5 Porter’s Fiver Forces Analysis	43
3 Segmentation of Global Market by Offering	47
3.1 Market Overview by Offering	47
3.2 Products	49
3.3.1 Probiotics	50
3.3.2 Prebiotics	51
3.3.3 Vitamins & Supplements	52
3.3 Testing Services	53
3.3.1 Nutrigenomics Clinical Testing	54
3.3.2 Nutrigenomics Research Testing	55
4 Segmentation of Global Market by Test Technology	56
4.1 Market Overview by Test Technology	56
4.2 Next-generation Sequencing	58
4.3 Real-time PCR	59
4.4 DNA Microarray	60
4.5 Sanger Sequencing	61
5 Segmentation of Global Market by Test Sample	62
5.1 Market Overview by Test Sample	62
5.2 Buccal Swab Sample	64
5.3 Saliva Sample	65
5.4 Blood Sample	66
5.5 Other Samples	67
6 Segmentation of Global Market by Application	68
6.1 Market Overview by Application	68
6.2 Women’s Health	70
6.3 Metabolic Disorders	71
6.4 Immune Health	72
6.5 Cancer Research	73
6.6 Cardiovascular Diseases	74
6.7 Diabetes	75
6.8 Other Applications	76
7 Segmentation of Global Market by End User	77
7.1 Market Overview by End User	77
7.2 Hospitals	79
7.3 Nutrition Clinics	80
7.4 Diagnostics Laboratories	81
7.5 Other End Users	82
8 Segmentation of Global Market by Region	83
8.1 Geographic Market Overview 2021-2031	83
8.2 North America Market 2021-2031 by Country	87
8.2.1 Overview of North America Market	87
8.2.2 U.S.	91
8.2.3 Canada	94
8.2.4 Mexico	96
8.3 European Market 2021-2031 by Country	98
8.3.1 Overview of European Market	98
8.3.2 Germany	102
8.3.3 U.K.	104
8.3.4 France	106
8.3.5 Spain	108
8.3.6 Italy	110
8.3.7 Netherlands	112
8.3.8 Rest of European Market	114
8.4 Asia-Pacific Market 2021-2031 by Country	116
8.4.1 Overview of Asia-Pacific Market	116
8.4.2 Japan	120
8.4.3 China	123
8.4.4 Australia	125
8.4.5 India	127
8.4.6 South Korea	129
8.4.7 Rest of APAC Region	131
8.5 South America Market 2021-2031 by Country	133
8.5.1 Argentina	136
8.5.2 Brazil	138
8.5.3 Chile	140
8.5.4 Rest of South America Market	142
8.6 MEA Market 2021-2031 by Country	143
8.6.1 UAE	146
8.6.2 Saudi Arabia	148
8.6.3 South Africa	150
8.6.4 Other National Markets	152
9 Competitive Landscape	153
9.1 Overview of Key Vendors	153
9.2 New Product Launch, Partnership, Investment, and M&A	157
9.3 Company Profiles	158
BASF SE	158
BioGaia	160
Cell Logic	161
Cura Integrative Medicine	162
DNAfit	163
DuPont de Nemours, Inc.	164
Garden of Life, LLC	165
GeneOmbio	166
Genova Diagnostics, Inc.	167
GX Sciences, Inc.	168
Ingredion Incorporated	169
Jarrow Formulas Inc.	170
Koninklijke DSM N.V.	171
MedGenome	172
Metagenics, Inc.	173
Nutrigenomix Inc.	174
Unilever Group	175
XCODE Life	176
Yakult Honsha Co., Ltd.	177
RELATED REPORTS	178
List of Tables:

Table 1.  Snapshot of Global Nutrigenomics Market in Balanced Perspective, 2021-2031	19
Table 2. World Economic Outlook, 2021-2031	23
Table 3. World Economic Outlook, 2021-2023	24
Table 4. World Health Spending by Region, $ bn, 2013-2020	35
Table 5.  Main Product Trends and Market Opportunities in Global Nutrigenomics Market	39
Table 6. Global Nutrigenomics Market by Offering, 2021-2031, $ mn	47
Table 7. Global Nutrigenomics Market: Products by Type, 2021-2031, $ mn	49
Table 8. Global Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn	53
Table 9. Global Nutrigenomics Market by Test Technology, 2021-2031, $ mn	56
Table 10. Global Nutrigenomics Market by Test Sample, 2021-2031, $ mn	62
Table 11. Global Nutrigenomics Market by Application, 2021-2031, $ mn	68
Table 12. Global Nutrigenomics Market by End User, 2021-2031, $ mn	77
Table 13. Global Nutrigenomics Market by Region, 2021-2031, $ mn	84
Table 14.  Leading National Nutrigenomics Market, 2021 and 2031, $ mn	86
Table 15. North America Nutrigenomics Market by Country, 2021-2031, $ mn	89
Table 16. U.S. Nutrigenomics Market by Offering, 2021-2031, $ mn	93
Table 17. U.S. Nutrigenomics Market by Application, 2021-2031, $ mn	93
Table 18. U.S. Nutrigenomics Market by End User, 2021-2031, $ mn	93
Table 19. Canada Nutrigenomics Market by Offering, 2021-2031, $ mn	95
Table 20. Canada Nutrigenomics Market by Application, 2021-2031, $ mn	95
Table 21. Canada Nutrigenomics Market by End User, 2021-2031, $ mn	95
Table 22. Mexico Nutrigenomics Market by Offering, 2021-2031, $ mn	97
Table 23. Mexico Nutrigenomics Market by Application, 2021-2031, $ mn	97
Table 24. Mexico Nutrigenomics Market by End User, 2021-2031, $ mn	97
Table 25. Europe Nutrigenomics Market by Country, 2021-2031, $ mn	101
Table 26. Germany Nutrigenomics Market by Offering, 2021-2031, $ mn	103
Table 27. Germany Nutrigenomics Market by Application, 2021-2031, $ mn	103
Table 28. Germany Nutrigenomics Market by End User, 2021-2031, $ mn	103
Table 29. U.K. Nutrigenomics Market by Offering, 2021-2031, $ mn	105
Table 30. U.K. Nutrigenomics Market by Application, 2021-2031, $ mn	105
Table 31. U.K. Nutrigenomics Market by End User, 2021-2031, $ mn	105
Table 32. France Nutrigenomics Market by Offering, 2021-2031, $ mn	107
Table 33. France Nutrigenomics Market by Application, 2021-2031, $ mn	107
Table 34. France Nutrigenomics Market by End User, 2021-2031, $ mn	107
Table 35. Spain Nutrigenomics Market by Offering, 2021-2031, $ mn	109
Table 36. Spain Nutrigenomics Market by Application, 2021-2031, $ mn	109
Table 37. Spain Nutrigenomics Market by End User, 2021-2031, $ mn	109
Table 38. Italy Nutrigenomics Market by Offering, 2021-2031, $ mn	111
Table 39. Italy Nutrigenomics Market by Application, 2021-2031, $ mn	111
Table 40. Italy Nutrigenomics Market by End User, 2021-2031, $ mn	111
Table 41. Netherlands Nutrigenomics Market by Offering, 2021-2031, $ mn	113
Table 42. Netherlands Nutrigenomics Market by Application, 2021-2031, $ mn	113
Table 43. Netherlands Nutrigenomics Market by End User, 2021-2031, $ mn	113
Table 44. Nutrigenomics Market in Rest of Europe by Country, 2021-2031, $ mn	115
Table 45. APAC Nutrigenomics Market by Country, 2021-2031, $ mn	118
Table 46. Japan Nutrigenomics Market by Offering, 2021-2031, $ mn	122
Table 47. Japan Nutrigenomics Market by Application, 2021-2031, $ mn	122
Table 48. Japan Nutrigenomics Market by End User, 2021-2031, $ mn	122
Table 49. China Nutrigenomics Market by Offering, 2021-2031, $ mn	124
Table 50. China Nutrigenomics Market by Application, 2021-2031, $ mn	124
Table 51. China Nutrigenomics Market by End User, 2021-2031, $ mn	124
Table 52. Australia Nutrigenomics Market by Offering, 2021-2031, $ mn	126
Table 53. Australia Nutrigenomics Market by Application, 2021-2031, $ mn	126
Table 54. Australia Nutrigenomics Market by End User, 2021-2031, $ mn	126
Table 55. India Nutrigenomics Market by Offering, 2021-2031, $ mn	128
Table 56. India Nutrigenomics Market by Application, 2021-2031, $ mn	128
Table 57. India Nutrigenomics Market by End User, 2021-2031, $ mn	128
Table 58. South Korea Nutrigenomics Market by Offering, 2021-2031, $ mn	130
Table 59. South Korea Nutrigenomics Market by Application, 2021-2031, $ mn	130
Table 60. South Korea Nutrigenomics Market by End User, 2021-2031, $ mn	130
Table 61. Nutrigenomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn	132
Table 62. South America Nutrigenomics Market by Country, 2021-2031, $ mn	135
Table 63. Argentina Nutrigenomics Market by Offering, 2021-2031, $ mn	137
Table 64. Argentina Nutrigenomics Market by Application, 2021-2031, $ mn	137
Table 65. Argentina Nutrigenomics Market by End User, 2021-2031, $ mn	137
Table 66. Brazil Nutrigenomics Market by Offering, 2021-2031, $ mn	139
Table 67. Brazil Nutrigenomics Market by Application, 2021-2031, $ mn	139
Table 68. Brazil Nutrigenomics Market by End User, 2021-2031, $ mn	139
Table 69. Chile Nutrigenomics Market by Offering, 2021-2031, $ mn	141
Table 70. Chile Nutrigenomics Market by Application, 2021-2031, $ mn	141
Table 71. Chile Nutrigenomics Market by End User, 2021-2031, $ mn	141
Table 72. MEA Nutrigenomics Market by Country, 2021-2031, $ mn	145
Table 73. UAE Nutrigenomics Market by Offering, 2021-2031, $ mn	147
Table 74. UAE Nutrigenomics Market by Application, 2021-2031, $ mn	147
Table 75. UAE Nutrigenomics Market by End User, 2021-2031, $ mn	147
Table 76. Saudi Arabia Nutrigenomics Market by Offering, 2021-2031, $ mn	149
Table 77. Saudi Arabia Nutrigenomics Market by Application, 2021-2031, $ mn	149
Table 78. Saudi Arabia Nutrigenomics Market by End User, 2021-2031, $ mn	149
Table 79. South Africa Nutrigenomics Market by Offering, 2021-2031, $ mn	151
Table 80. South Africa Nutrigenomics Market by Application, 2021-2031, $ mn	151
Table 81. South Africa Nutrigenomics Market by End User, 2021-2031, $ mn	151
Table 82. Breakdown of World Nutrigenomics Products Market by Key Vendor, 2021, %	155
Table 83. Breakdown of World Nutrigenomics Testing Services Market by Key Vendor, 2021, %	155
Table 84. BASF SE: Company Snapshot	158
Table 85. BASF SE: Business Segmentation	159
Table 86. BASF SE: Product Portfolio	159
List of Figures:

Figure 1. Research Method Flow Chart	13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	18
Figure 4. Global Nutrigenomics Market, 2021-2031, $ mn	21
Figure 5. Impact of COVID-19 on Business	26
Figure 6. Primary Drivers and Impact Factors of Global Nutrigenomics Market	28
Figure 7. Number of Overweight/Obese People and Diabetic Population in the World, 1980, 2020, and 2045F, in million	31
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	33
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	34
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	34
Figure 11. Primary Restraints and Impact Factors of Global Nutrigenomics Market	36
Figure 12. Investment Opportunity Analysis	40
Figure 13. Porter’s Fiver Forces Analysis of Global Nutrigenomics Market	43
Figure 14. Breakdown of Global Nutrigenomics Market by Offering, 2021-2031, % of Revenue	48
Figure 15. Global Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	48
Figure 16. Global Nutrigenomics Market by Offering: Products, 2021-2031, $ mn	49
Figure 17. Global Nutrigenomics Market by Products: Probiotics, 2021-2031, $ mn	50
Figure 18. Global Nutrigenomics Market by Products: Prebiotics, 2021-2031, $ mn	51
Figure 19. Global Nutrigenomics Market by Products: Vitamins & Supplements, 2021-2031, $ mn	52
Figure 20. Global Nutrigenomics Market by Offering: Testing Services, 2021-2031, $ mn	53
Figure 21. Global Nutrigenomics Market by Testing Services: Nutrigenomics Clinical Testing, 2021-2031, $ mn	54
Figure 22. Global Nutrigenomics Market by Testing Services: Nutrigenomics Research Testing, 2021-2031, $ mn	55
Figure 23. Breakdown of Global Nutrigenomics Market by Test Technology, 2021-2031, % of Sales Revenue	57
Figure 24. Global Addressable Market Cap in 2022-2031 by Test Technology, Value ($ mn) and Share (%)	57
Figure 25. Global Nutrigenomics Market by Test Technology: Next-generation Sequencing, 2021-2031, $ mn	58
Figure 26. Global Nutrigenomics Market by Test Technology: Real-time PCR, 2021-2031, $ mn	59
Figure 27. Global Nutrigenomics Market by Test Technology: DNA Microarray, 2021-2031, $ mn	60
Figure 28. Global Nutrigenomics Market by Test Technology: Sanger Sequencing, 2021-2031, $ mn	61
Figure 29. Breakdown of Global Nutrigenomics Market by Test Sample, 2021-2031, % of Sales Revenue	63
Figure 30. Global Addressable Market Cap in 2022-2031 by Test Sample, Value ($ mn) and Share (%)	63
Figure 31. Global Nutrigenomics Market by Test Sample: Buccal Swab Sample, 2021-2031, $ mn	64
Figure 32. Global Nutrigenomics Market by Test Sample: Saliva Sample, 2021-2031, $ mn	65
Figure 33. Global Nutrigenomics Market by Test Sample: Blood Sample, 2021-2031, $ mn	66
Figure 34. Global Nutrigenomics Market by Test Sample: Other Samples, 2021-2031, $ mn	67
Figure 35. Breakdown of Global Nutrigenomics Market by Application, 2021-2031, % of Revenue	69
Figure 36. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	69
Figure 37. Global Nutrigenomics Market by Application: Women’s Health, 2021-2031, $ mn	70
Figure 38. Global Nutrigenomics Market by Application: Metabolic Disorders, 2021-2031, $ mn	71
Figure 39. Global Nutrigenomics Market by Application: Immune Health, 2021-2031, $ mn	72
Figure 40. Global Nutrigenomics Market by Application: Cancer Research, 2021-2031, $ mn	73
Figure 41. Global Nutrigenomics Market by Application: Cardiovascular Diseases, 2021-2031, $ mn	74
Figure 42. Global Nutrigenomics Market by Application: Diabetes, 2021-2031, $ mn	75
Figure 43. Global Nutrigenomics Market by Application: Other Applications, 2021-2031, $ mn	76
Figure 44. Breakdown of Global Nutrigenomics Market by End User, 2021-2031, % of Revenue	78
Figure 45. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	78
Figure 46. Global Nutrigenomics Market by End User: Hospitals, 2021-2031, $ mn	79
Figure 47. Global Nutrigenomics Market by End User: Nutrition Clinics, 2021-2031, $ mn	80
Figure 48. Global Nutrigenomics Market by End User: Diagnostics Laboratories, 2021-2031, $ mn	81
Figure 49. Global Nutrigenomics Market by End User: Other End Users, 2021-2031, $ mn	82
Figure 50.  Global Market Snapshot by Region	83
Figure 51.  Geographic Spread of Worldwide Nutrigenomics Market, 2021-2031, % of Sales Revenue	84
Figure 52. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)	85
Figure 53.  North American Nutrigenomics Market, 2021-2031, $ mn	88
Figure 54. Breakdown of North America Nutrigenomics Market by Country, 2021 and 2031, % of Revenue	89
Figure 55. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	90
Figure 56. U.S. Nutrigenomics Market, 2021-2031, $ mn	92
Figure 57. Canada Nutrigenomics Market, 2021-2031, $ mn	94
Figure 58.  Nutrigenomics Market in Mexico, 2021-2031, $ mn	96
Figure 59.  European Nutrigenomics Market, 2021-2031, $ mn	99
Figure 60. Breakdown of European Nutrigenomics Market by Country, 2021 and 2031, % of Revenue	100
Figure 61. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	101
Figure 62.  Nutrigenomics Market in Germany, 2021-2031, $ mn	102
Figure 63.  Nutrigenomics Market in U.K., 2021-2031, $ mn	104
Figure 64.  Nutrigenomics Market in France, 2021-2031, $ mn	106
Figure 65.  Nutrigenomics Market in Spain, 2021-2031, $ mn	108
Figure 66.  Nutrigenomics Market in Italy, 2021-2031, $ mn	110
Figure 67.  Nutrigenomics Market in Netherlands, 2021-2031, $ mn	112
Figure 68.  Nutrigenomics Market in Rest of Europe, 2021-2031, $ mn	114
Figure 69. Asia-Pacific Nutrigenomics Market, 2021-2031, $ mn	117
Figure 70. Breakdown of APAC Nutrigenomics Market by Country, 2021 and 2031, % of Revenue	117
Figure 71. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	119
Figure 72.  Nutrigenomics Market in Japan, 2021-2031, $ mn	121
Figure 73.  Nutrigenomics Market in China, 2021-2031, $ mn	123
Figure 74.  Nutrigenomics Market in Australia, 2021-2031, $ mn	125
Figure 75.  Nutrigenomics Market in India, 2021-2031, $ mn	127
Figure 76.  Nutrigenomics Market in South Korea, 2021-2031, $ mn	129
Figure 77.  Nutrigenomics Market in Rest of APAC, 2021-2031, $ mn	131
Figure 78. South America Nutrigenomics Market, 2021-2031, $ mn	134
Figure 79. Breakdown of South America Nutrigenomics Market by Country, 2021 and 2031, % of Revenue	134
Figure 80. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	135
Figure 81.  Nutrigenomics Market in Argentina, 2021-2031, $ mn	136
Figure 82.  Nutrigenomics Market in Brazil, 2021-2031, $ mn	138
Figure 83.  Nutrigenomics Market in Chile, 2021-2031, $ mn	140
Figure 84.  Nutrigenomics Market in Rest of South America, 2021-2031, $ mn	142
Figure 85. Nutrigenomics Market in Middle East and Africa (MEA), 2021-2031, $ mn	144
Figure 86. Breakdown of MEA Nutrigenomics Market by Country, 2021 and 2031, % of Revenue	144
Figure 87. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	145
Figure 88.  Nutrigenomics Market in UAE, 2021-2031, $ mn	146
Figure 89.  Nutrigenomics Market in Saudi Arabia, 2021-2031, $ mn	148
Figure 90.  Nutrigenomics Market in South Africa, 2021-2031, $ mn	150
Figure 91. Growth Stage of Global Nutrigenomics Industry over the Forecast Period	153
Selected Key Players: 
BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)